Veraxa Biotech AG (VRXAW) Stock Ticker
Market factors today
Unlock the full VRXAW picture
About Veraxa Biotech AG
Veraxa Biotech AG is a clinical-stage biopharmaceutical company specializing in next-generation antibody-based cancer therapies. [9] The company is advancing a drug discovery and development engine for ADCs and other novel antibody-based therapy concepts. [14] It was founded on scientific breakthroughs made at the European Molecular Biology Laboratory (EMBL). [8, 14]
VRXAW stock facts
| Ticker symbol | VRXAW |
| Exchange | NASDAQ Global Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $1.8M |
| CEO | Christoph Antz |
| Employees | 47 |
| Headquarters | Heidelberg, ZH, DE |
| IPO date | 2026-06-10 |
| Website | www.veraxa.com |
What you can see for VRXAW on Tickr
Live VRXAW price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the VRXAW report.
Rankings
FAQ
What is the ticker symbol for Veraxa Biotech AG?
The ticker symbol for Veraxa Biotech AG is VRXAW, listed on the NASDAQ Global Market.
What is VRXAW?
Veraxa Biotech AG is a clinical-stage biopharmaceutical company specializing in next-generation antibody-based cancer therapies. [9] The company is advancing a drug discovery and development engine for ADCs and other novel antibody-based therapy concepts. [14] It was founded on scientific breakthroughs made at the European Molecular Biology Laboratory (EMBL). [8, 14]